Report Code: A04018 | Pages: NA | Mar 2023 | 6157 Views | ||
Author(s) : NA | Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Medical Contrast Agent Market
Request Now !Medical contrast agent is a material used in medical imaging to improve the contrast of structure or fluids inside a body. The contrast agents provide enhanced visibility for observation of blood vessels and the gastrointestinal tract. According to the imaging modalities such as x-ray and ultrasound, an array of contrast reagents is used as per requirement of the imaging technique.
The medical contrast agent market is driven by growth in approval of contrast agents and increase in number of private diagnostics clinics & services. Moreover, technological development in diagnostics imaging and strong product pipeline of market players are expected to boost the market growth. However, high cost of medical imaging equipment and lack of skilled professionals in the industry may impede this growth.
The global medical contrast agent market is segmented based on type, procedure, route of administration, indication, application, and region. Based on type, it is classified into barium-based contrast media, iodinated contrast media, gadolinium-based contrast media, and microbubble contrast media. Based on procedure, it is segmented into X-ray/computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound. Based on route of administration, it is categorized into oral contrast media, injectable contrast media, rectal contrast media, and urethral contrast media.
Based on indication, it is divided into cardiovascular disorders, oncology, gastrointestinal disorders, musculoskeletal disorders, neurological disorders, and nephrological disorders. The application segment includes radiology, interventional radiology, and interventional cardiology. Based on region, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. These regions are further analyzed across the country level to determine the market size and forecast for each segment and sub-segment.
Comprehensive competitive analysis and profiles of major players, such as GE Healthcare, Bayer AG, Bracco Imaging S.P.A., Guerbet Group, Lantheus Medical Imaging, Nanopet Pharma GmbH, CMC Contrast AB, Daiichi Sankyo, Subhra Pharma Private Limited, and Spago Nanomedical AB, are provided in this report.
Key Benefits
Medical Contrast Agent Market Report Highlights
Aspects | Details |
---|---|
By Type |
|
By Procedure |
|
By Route of Administration |
|
By Indication |
|
By Application |
|
By Region |
|
Key Market Players | GE Healthcare, Bayer AG, Bracco Imaging S.P.A., Guerbet Group, Lantheus Medical Imaging, Nanopet Pharma GmbH, CMC Contrast AB, Daiichi Sankyo, Subhra Pharma Private Limited, Spago Nanomedical AB |
Loading Table Of Content...
Start reading.
This Report and over 19,661+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers